McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Emerging Leaders 2024: Carrie Williams, McKesson Ventures

by McKesson Ventures | Mar 11, 2024 | Media Coverage

McKesson Ventures Vice President and Partner Carrie (Hurwitz) Williams was named as one of Global Corporate Venturing (GCV)’s top “Emerging Leaders for 2024”! Announced on Monday, March 11th, Williams was praised by GCV for her experience with “the business...

McKesson Ventures’ Carrie Williams Speaks at 2023 DHIS Conference

by McKesson Ventures | Jun 9, 2023 | Industry News, Media Coverage

McKesson Ventures Vice President & Partner Carrie Williams spoke at the Digital Healthcare Innovation Summit, East Coast, which took place June 6 and 7, 2023, in Boston. Williams participated in a panel discussion titled “Beyond the Clinic: Digital &...

Covid-19 serves as catalyst for effort to diversity clinical trial enrollment

by McKesson Ventures | Apr 23, 2021 | Media Coverage

McKesson Ventures Vice President and Partner Carrie Williams was a speaker on a panel at MedCity’s INVEST conference, April 22, 2021. She and the other panelists, Allison Kalloo, founder and president of Clinical Ambassador; Doug Langa, executive vice president of...

Recent Posts

  • Atropos Health CEO Brigham Hyde Discusses Healthcare and Medical Technology Trends With McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast
  • Latent Raises $80M to Close the Gap Between Diagnosis and Treatment
  • Midi Health Surpasses $1B Valuation, Igniting a New Era for Women’s Health
  • Oath Surgical Announces AI-Native Surgical Centers Powered by NVIDIA
  • Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings